Rechargeable implant offers hope for bladder control – but does it last?

NCT ID NCT06789406

First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 33 times

Summary

This study is following 55 adults who have an implanted device that stimulates nerves to control overactive bladder. Researchers want to see if the device safely improves quality of life over the long term. Participants must have already tried other treatments without success.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVERACTIVE BLADDER (OAB) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Bradford Royal Infirmary

    RECRUITING

    Bradford, West Yorkshire, BD96RJ, United Kingdom

    Contact

    Contact

    Contact

  • Pinderfields Hospital

    RECRUITING

    Wakefield, West Yorkshire, WF1 4DG, United Kingdom

    Contact

    Contact

  • University College London Hospital

    RECRUITING

    London, W1G 8PH, United Kingdom

    Contact

    Contact

  • University of Chicago

    RECRUITING

    Chicago, Illinois, 60637, United States

    Contact

    Contact

  • University of Missouri

    RECRUITING

    Columbia, Missouri, 65211, United States

    Contact

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

rechargeable Axonics SNM system (a nerve-stimulating device implanted in the body)

What this could lead to

If successful, this could confirm that the device provides lasting relief from overactive bladder symptoms and improves quality of life for years.

What could go wrong

This is a post-market study with only 55 participants, so results may not apply to everyone. The device requires surgery and carries risks like infection or device malfunction.

Conditions

The condition(s) this trial relates to.

overactive bladder Urinary Incontinence, Urge

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.